51
TITLE: Bone mineral density, bone histomorphometric analysis and vascular calcifications in hemodialysis patients
AUTHORS: Adragao, T; Ferreira, A; Frazao, JM ; Gil, C; Oliveira, C; Galvao, J; Sarmento, M; Ribeiro, S; Dickson, J; Carvalho, B; Rodrigues, I; Baldaia, J; Pereira, O; Faugere, MC; Malluche, HH;
PUBLISHED: 2007, SOURCE: 44th ERA-EDTA Congress in NEPHROLOGY DIALYSIS TRANSPLANTATION, VOLUME: 22
INDEXED IN: WOS
52
TITLE: Early use of cinacalcet (MIMPARA (R)/SENSIPAR (R)) in dialysis patients enables greatest achievement of NKF-KDOQI (TM) treatment targets for bone metabolism
AUTHORS: Frazao, JM ; Messa, P; Cunningham, J; Evenepoel, P; Shahapuni, I; Urena, P; Braun, J; Zani, V; Banos, A; Molemans, B; de Francisco, ALM;
PUBLISHED: 2006, SOURCE: 43rd Annual Congress of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA) in NEPHROLOGY DIALYSIS TRANSPLANTATION, VOLUME: 21
INDEXED IN: WOS
53
TITLE: Effects of sevelamer and calcium carbonate on bone mineralisation and turnover in chronic maintenance haemodialysis patients
AUTHORS: Anibal Ferreira; Joao Miguel Frazao ; Marie Claude Faugere; Regula Mueller; Hartmut Malluche;
PUBLISHED: 2006, SOURCE: 43rd ERA-EDTA Congress in NEPHROLOGY DIALYSIS TRANSPLANTATION, VOLUME: 21
INDEXED IN: WOS
54
TITLE: The Optima study: Earlier intervention of Cinacalcet HCl (Sensipar (R)/Mimpara (R)) enables greater achievement of KDOQI (TM) secondary hyperparathyroidism (SHPT) targets in dialysis patients.
AUTHORS: Frazao, JM ; Macario, F; Yaqoob, M; Bouman, K; Braun, J; von Albertini, B; Brink, HS; Maduell, F; Graf, H; Saha, H; Zani, V; Carter, D; Molemans, B; Messa, P;
PUBLISHED: 2006, SOURCE: Spring Clinical Meeting of the National-Kidney-Foundation in AMERICAN JOURNAL OF KIDNEY DISEASES, VOLUME: 47, ISSUE: 4
INDEXED IN: WOS
55
TITLE: Vascular calcifications and bone turnover in hemodialysis patients
AUTHORS: Adragao, T; Ferreira, A; Frazao, JM ; Gil, C; Oliveira, C; Galvao, J; Sarmento, M; Ribeiro, S; Dickson, J; Carvalho, B; Rodrigues, I; Baldaia, J; Pereira, O; Faugere, MC; Malluche, HH;
PUBLISHED: 2006, SOURCE: 43rd ERA-EDTA Congress in NEPHROLOGY DIALYSIS TRANSPLANTATION, VOLUME: 21
INDEXED IN: WOS
56
TITLE: Cinacalcet (MIMPARA (R)/SENSIPAR (R)) maintains achievement of NKF-K/DOQI treatment targets for secondary hyperparathyroidism (HPT) in patients on dialysis
AUTHORS: Frazao, JM ; Holzer, H; Stummvoll, HK; Bahner, U; Wilkie, M; Zani, V; Hutton, H; Motellon, JL; Braun, J;
PUBLISHED: 2005, SOURCE: 42nd Annual Meeting of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA) in NEPHROLOGY DIALYSIS TRANSPLANTATION, VOLUME: 20
INDEXED IN: WOS
57
TITLE: Calcimimetic agents: Review and perspectives
AUTHORS: Urena, P; Frazao, JM ;
PUBLISHED: 2003, SOURCE: Kidney International, Supplement, VOLUME: 63, ISSUE: 85
INDEXED IN: Scopus
IN MY: ORCID
58
TITLE: Calcimimetic agents: Review and perspectives  Full Text
AUTHORS: Urena, P; Frazao, JM ;
PUBLISHED: 2003, SOURCE: 4th Symposium on Advances in Renal Osteodystrophy in KIDNEY INTERNATIONAL, VOLUME: 63
INDEXED IN: WOS
59
TITLE: Cinacalcet HCI is an effective primary therapy for the management of secondary hyperparathyroidism (HPT).
AUTHORS: Goodman, WG; Fadda, GZ; Finkelstein, FO; Mittman, N; Lien, YH; Leblanc, M; Locatelli, F; Frazao, JM ; Olgaard, K; Olson, KA; McCary, LC; Turner, SA; Quarles, LD;
PUBLISHED: 2003, SOURCE: 36th Annual Meeting of the American-Society-of-Nephrology in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, VOLUME: 14
INDEXED IN: WOS
60
TITLE: The calcimimetic agents: Perspectives for treatment  Full Text
AUTHORS: Frazao, JM ; Martins, P; Coburn, JW;
PUBLISHED: 2002, SOURCE: 1st International Conference on New Insights in End-Stage Renal Disease in KIDNEY INTERNATIONAL, VOLUME: 61, ISSUE: 80
INDEXED IN: Scopus WOS
Page 6 of 8. Total results: 74.